首页> 外文期刊>Current Bioinformatics >Progress onAmpC β-lactamases
【24h】

Progress onAmpC β-lactamases

机译:进展Onampcβ-内酰胺酶

获取原文
获取原文并翻译 | 示例
           

摘要

The predominant mechanism for resistance to -lactam antimicrobial agents in gram-negative bacteria is thesynthesis of -lactamases, which are capable of hydrolyzing -lactam ring. AmpC -lactamases which are termed classC/group 1, by mutation, are one of the most important -lactamases in gram-negative bacteria. They provide resistance tooxyimino-, 7--methoxy- cephalosporins and monobactams, however, are not blocked by commercially available inhibitors.In recent 10 years, the resistant mechanism of plasmid-mediated AmpC -lactamases has been more and more commonin the world. The transferability of the resistance genes can result in the nosocomial dissemination of resistantstrains, which is serious challenge to the treatment of seriously mortal infection. Therefore, progression of AmpC -lactamases is described from six aspects in the mini-review, including: a brief development history, molecular characteristics, structure, function, and regulatory mechanisms, molecular epidemiology, detection, treatment. It isprobably useful of the reasonable choice of antimicrobial agents, powerful monitoring of bacterial resistance, and thefurther study on resistant mechanism.
机译:用于革兰氏阴性细菌中抗酰胺抗菌剂的抗性抗菌剂的主要机理是 - 酰胺酶的合成,其能够水解 - 酰胺环。 ampc -lactamases被称为类C /族1,突变是革兰氏阴性细菌中最重要的 - 酰胺酶之一。他们提供抵抗力然而,Othimino -,7 - 甲氧基 - 头孢菌素和单酰胺不受市售的抑制剂阻断。近10年来,质粒介导的AMPC - 酰胺酶的抗性机制越来越普遍在世界上。抗性基因的可转移可导致抗性的医院传播菌株是对治疗严重致命感染的严重挑战。因此,AMPC的进展 - 迷你评论中的六个方面描述了乳酰胺酶,包括:简要的开发历史,分子特征, 结构,功能和调节机制,分子流行病学,检测,治疗。这是可能有助于合理选择抗微生物剂,强大的细菌抗性监测,以及进一步研究抗性机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号